Jan 22, 2018 - Stifel issues rating change for ARRY
Jan 09, 2018 - The following slide deck was published by Array BioPharma Inc. in conjunction with this event.
Jan 07, 2018 - Deals and Financings Perennial Real Estate Holdings (SGX: 40S), a Singapore company, announced a $1.2 billion joint venture that will acquire and develop healthcare centers in China. It plans to conce
Jan 04, 2018 - Ardelyx announced a significant drop in diarrhea incidence. Omeros reached an agreement with FDA on design of Phase 3 trial for OMS 721 in IgN. Allergan announced that it will cut more than 1,000 jobs
Dec 28, 2017 - December performance is picking up significantly.ROTY has gotten off to a great start and much of that is due to support from readers. In coming months the discussion will shift to future formats and
Dec 26, 2017 - Boulder drug development company Array BioPharma has spun off its research into a treatment for a rare degenerative heart disease into a separate company.
Array BioPharma (Nasdaq: ARRAY), in a filing to the U.S. Securities & Exchange Commission on Chistmas Eve, revealed that it had contributed intellectual property, inventory, equipment, clinical trial data and other material about its experimental cardiomyopathy drug to a subsidiary it’s calling Yarra Therapeutics.
The oral drug, known only…
Dec 26, 2017 - Amgen plans to repatriate some of its cash holdings kept outside the U.S. Roche acquired Ignyta, paying premium of more than 70%. Agile tumbled nearly 50% on CRL.
Dec 26, 2017 - Array BioPharma (ARRY) shares rose nearly 10% in the last trading session, amid huge volumes.
Dec 21, 2017 - I remind readers to check out my recent interview with Seeking Alpha Editor Steve Brown for my thoughts on the year ahead and themes that could work.Perceptive Advisors' stake in Global Blood Therape
Dec 20, 2017 - Despite the gains this year, Valeant still remains a risky bet.Onconova has signed an agreement with HanX of China.Array Biopharma announced collaboration with Pfizer.